Trends in utilization and survival after autologous hematopoietic cell transplantation in North America from 1995 to 2005: Significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age

Autologous hematopoietic cell transplantation (autoHCT) is used for relapsed and recurrent malignant disorders and as part of initial therapy for selected malignancies. This study describes changes in utilization, techniques and survival in a population–based cohort including 68,404 patients who und...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: McCarthy, Philip L., Hahn, Theresa, Hassebroek, Anna, Bredeson, Christopher, Gajewski, James, Hale, Gregory, Isola, Luis, Lazarus, Hillard M., Lee, Stephanie J., LeMaistre, Charles F., Loberiza, Fausto, Maziarz, Richard T., Rizzo, J. Douglas, Joffe, Steven, Parsons, Susan, Majhail, Navneet S.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3694566/
https://ncbi.nlm.nih.gov/pubmed/23660172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2013.04.027
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars